Anh Lockett
|Subscribers
About
In premenopausal women with polycystic ovary syndrome, ketoconazole has been found to significantly decrease levels of androstenedione and testosterone and significantly increase levels of 17α-hydroxyprogesterone and estradiol. Suppression of testosterone levels by ketoconazole is generally partial and has often been found to be transient. As an antifungal, ketoconazole is structurally similar to imidazole, and interferes with the fungal synthesis of ergosterol, a constituent of fungal cell membranes, as well as certain enzymes. Activated charcoal may be administered within the first hour following overdose of oral ketoconazole. It recommends oral tablets should not be a first-line treatment for any fungal infection. Other contraindications of oral ketoconazole include liver disease, adrenal insufficiency, and known hypersensitivity to oral ketoconazole. Ketoconazole has been used to prevent the testosterone flare at the initiation of GnRH agonist therapy in men with prostate cancer.
It also inhibits androgen and glucocorticoid synthesis. Thus the link to other proteins binding androgens might be possible. 24 hours after treatment, however, the response of plasma testosterone to hCG was diminished. The diminution of testosterone synthesis could be significant as further therapeutic trials may use larger doses or more than once-daily administration.
Since all tested imidazoles which suppress testosterone production have as a common feature a phenylated side chain of the imidazole molecule, this indicates a structure/activity relationship for the effects observed. In vitro studies with mouse Leydig cells demonstrated a direct reversible inhibition of testosterone biosynthesis by ketoconazole. Testosterone therapy suppresses sperm production, sometimes to zero, within months. This guide breaks down exactly when therapy helps, how it’s diagnosed, the safest treatments, and how to monitor results with confidence. In vivo perfusion of canine testes with ketoconazole inhibited the stimulation of testosterone production by human chorionic gonadotropin in a dose-dependent manner. Can ketoconazole shampoo be used to treat fungal infections on other parts of the body?
What should I do if I experience side effects from ketoconazole shampoo? Paradoxically, ketoconazole shampoo is sometimes used to treat certain types of hair loss, as the anti-inflammatory effects on the scalp can sometimes improve hair growth. Ketoconazole appears to be the first example of a non-steroidal compound which binds competitively to both SSBG and multiple steroid hormone receptors, suggesting that the ligand binding sites of these proteins share some features in common. It should be noted, however, that the dose of ketoconazole required for 50% occupancy of the androgen receptor is not likely to be achieved in vivo, at least in plasma. Additional binding studies performed with ketoconazole in the presence of increasing amounts of 3HR1881 showed that the interaction of ketoconazole with AR was competitive when the data were analyzed by the Scatchard method.
Fifty percent displacement of 3HR1881 binding to AR was achieved by 6.4 +/- 1.8 (SE) x 10(-5) M ketoconazole. Ketoconazole competition with 3Hmethyltrienolone (R1881) for androgen binding sites in dispersed, intact cultured human skin fibroblasts was determined at 22 degrees C. Oral ketoconazole has been replaced with oral fluconazole or itraconazole for many mycoses. Following its introduction, ketoconazole was the only systemic antifungal available for almost a decade. Studies in postmenopausal women with breast cancer have found that ketoconazole significantly decreases androstenedione levels, slightly decreases estradiol levels, and does not affect estrone levels.
Ketoconazole has also been found to decrease levels of endogenous corticosteroids, such as cortisol, corticosterone, and aldosterone, as well as vitamin D. As azole antifungals all act at the same point in the sterol pathway, resistant isolates are normally cross-resistant to all members of the azole family. Multidrug-resistance (MDR) genes can also play a role in reducing cellular levels of the drug.